Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker

Alzheimer's and Dementia

Volumn 10, Issue 1, 2014, Pages

  Van Rooden, Sanneke ^a   Versluis, Maarten J ^a   Liem, Michael K ^a   Milles, Julien ^a   Maier, Andrea B ^a   Oleksik, Ania M ^a   Webb, Andrew G ^a   Van Buchem, Mark A ^a   Van Der Grond, Jeroen ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AD pathology; Alzheimer's disease; Biomarker; Brain imaging; Human 7T MRI; Phase changes

Indexed keywords

AMYLOID;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL CORTEX; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TEMPORAL CORTEX; VASCULAR AMYLOIDOSIS; VERY ELDERLY;

AD PATHOLOGY; ALZHEIMER'S DISEASE; BIOMARKER; BRAIN IMAGING; HUMAN 7T MRI; PHASE CHANGES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBRAL CORTEX; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; STATISTICS, NONPARAMETRIC;

EID: 84891160568     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.02.002     Document Type: Article

References (50)

1. P.T. Nelson, H. Braak, and W.R. Markesbery Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship J Neuropathol Exp Neurol 68 2009 1 14
2. K.A. Johnson, M. Gregas, J.A. Becker, C. Kinnecom, D.H. Salat, and E.K. Moran et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy Ann Neurol 62 2007 229 234 (Pubitemid 47525398)
3. A. Lockhart, J.R. Lamb, T. Osredkar, L.I. Sue, J.N. Joyce, and L. Ye et al. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis Brain 130 2007 2607 2615 (Pubitemid 47511709)
4. M.D. Ikonomovic, W.E. Klunk, E.E. Abrahamson, C.A. Mathis, J.C. Price, and N.D. Tsopelas et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Brain 131 2008 1630 1645 (Pubitemid 351806448)
5. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, and D.P. Holt et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B Ann Neurol 55 2004 306 319 (Pubitemid 38269583)
6. H. Engler, A. Forsberg, O. Almkvist, G. Blomquist, E. Larsson, and I. Savitcheva et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease Brain 129 2006 2856 2866 (Pubitemid 44684508)
7. C.C. Rowe, S. Ng, U. Ackermann, S.J. Gong, K. Pike, and G. Savage et al. Imaging beta-amyloid burden in aging and dementia Neurology 68 2007 1718 1725 (Pubitemid 46763260)
8. B.J. Bacskai, M.P. Frosch, S.H. Freeman, S.B. Raymond, J.C. Augustinack, and K.A. Johnson et al. Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report Arch Neurol 64 2007 431 434 (Pubitemid 46425701)
9. C.C. Rowe, and V.L. Villemagne Brain amyloid imaging J Nucl Med 52 2011 1733 1740
10. S. van Rooden, M.L. Maat-Schieman, R.J. Nabuurs, L. van der Weerd, S. van Duijn, and S.G. van Duinen et al. Cerebral amyloidosis: postmortem detection with human 7.0-T MR imaging system Radiology 253 2009 788 796
11. H. Benveniste, G. Einstein, K.R. Kim, C. Hulette, and G.A. Johnson Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy Proc Natl Acad Sci U S A 96 1999 14079 14084
12. J. Zhang, P. Yarowsky, M.N. Gordon, G. Di Carlo, S. Munireddy, and P.C. van Zijl et al. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging Magn Reson Med 51 2004 452 457 (Pubitemid 38298656)
13. J.A. Helpern, S.P. Lee, M.F. Falangola, V.V. Dyakin, A. Bogart, and B. Ardekani et al. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease Magn Reson Med 51 2004 794 798 (Pubitemid 38420457)
14. S.P. Lee, M.F. Falangola, R.A. Nixon, K. Duff, and J.A. Helpern Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents Magn Reson Med 52 2004 538 544 (Pubitemid 39108965)
15. C.R. Jack Jr., M. Garwood, T.M. Wengenack, B. Borowski, G.L. Curran, and J. Lin et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent Magn Reson Med 52 2004 1263 1271 (Pubitemid 39612814)
16. N. Braakman, J. Matysik, S.G. van Duinen, F. Verbeek, R. Schliebs, and H.J. de Groot et al. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging J Magn Reson Imaging 24 2006 530 536 (Pubitemid 44320553)
17. G. Vanhoutte, I. Dewachter, P. Borghgraef, F. Van Leuven, and A. Van der Linden Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice: a model for Alzheimer's disease Magn Reson Med 53 2005 607 613 (Pubitemid 40332281)
18. T. Nakada, H. Matsuzawa, H. Igarashi, Y. Fujii, and I.L. Kwee In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system J Neuroimaging 18 2008 125 129 (Pubitemid 351463961)
19. M.D. Meadowcroft, J.R. Connor, M.B. Smith, and Q.X. Yang MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice J Magn Reson Imaging 29 2009 997 1007
20. M.F. Falangola, S.P. Lee, R.A. Nixon, K. Duff, and J.A. Helpern Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice Neurochem Res 30 2005 201 205 (Pubitemid 40569203)
21. I. Grundke-Iqbal, J. Fleming, Y.C. Tung, H. Lassmann, K. Iqbal, and J.G. Joshi Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia Acta Neuropathol 81 1990 105 110
22. El Tannir, N. El Tayara, B. Delatour, C. Le Cudennec, M. Guegan, A. Volk, and M. Dhenain Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease Neurobiol Dis 22 2006 199 208
23. C. Exley Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta-{42} in senile plaque cores in Alzheimer's disease J Alzheimers Dis 10 2006 173 177
24. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, and W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J Neurol Sci 158 1998 47 52 (Pubitemid 28277534)
25. R.J. Ogg, J.W. Langston, E.M. Haacke, R.G. Steen, and J.S. Taylor The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration Magn Reson Imaging 17 1999 1141 1148 (Pubitemid 29444639)
26. E.M. Haacke, N.Y. Cheng, M.J. House, Q. Liu, J. Neelavalli, and R.J. Ogg et al. Imaging iron stores in the brain using magnetic resonance imaging Magn Reson Imaging 23 2005 1 25 (Pubitemid 40269946)
27. E.M. Haacke, M. Ayaz, A. Khan, E.S. Manova, B. Krishnamurthy, and L. Gollapalli et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain J Magn Reson Imaging 26 2007 256 264 (Pubitemid 47257722)
28. B. Yao, T.Q. Li, P. van Gelderen, K. Shmueli, J.A. de Zwart, and J.H. Duyn Susceptibility contrast in high field MRI of human brain as a function of tissue iron content Neuroimage 44 2009 1259 1266
29. J.H. Duyn, P. van Gelderen, T.Q. Li, J.A. de Zwart, A.P. Koretsky, and M. Fukunaga High-field MRI of brain cortical substructure based on signal phase Proc Natl Acad Sci U S A 104 2007 11796 11801 (Pubitemid 47175092)
30. M. Fukunaga, T.Q. Li, P. van Gelderen, J.A. de Zwart, K. Shmueli, and B. Yao et al. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast Proc Natl Acad Sci U S A 107 2010 3834 3839
31. N. Lynoe, M. Sandlund, G. Dahlqvist, and L. Jacobsson Informed consent: study of quality of information given to participants in a clinical trial BMJ 303 1991 610 613
32. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944 (Pubitemid 14076461)
33. S.M. Greenberg Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment Neurology 51 1998 690 694 (Pubitemid 28449244)
34. M.J. Versluis, J.M. Peeters, S. van Rooden, J. van der Grond, M.A. van Buchem, and A.G. Webb et al. Origin and reduction of motion and f0 artifacts in high resolution T2*-weighted magnetic resonance imaging: application in Alzheimer's disease patients Neuroimage 51 2010 1082 1088
35. M. Schar, S. Kozerke, S.E. Fischer, and P. Boesiger Cardiac SSFP imaging at 3 Tesla Magn Reson Med 51 2004 799 806 (Pubitemid 38420458)
36. E.M. Haacke, Y. Xu, Y.C. Cheng, and J.R. Reichenbach Susceptibility weighted imaging (SWI) Magn Reson Med 52 2004 612 618 (Pubitemid 39108975)
37. J.H. Duyn The future of ultra-high field MRI and fMRI for study of the human brain Neuroimage 62 2011 1241 1248
38. J.A. Duce, A. Tsatsanis, M.A. Cater, S.A. James, E. Robb, and K. Wikhe et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 142 2010 857 867
39. P. Lei, S. Ayton, D.I. Finkelstein, L. Spoerri, G.D. Ciccotosto, and D.K. Wright et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export Nat Med 18 2012 291 295
40. M.A. Smith, P.L. Harris, L.M. Sayre, and G. Perry Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc Natl Acad Sci U S A 94 1997 9866 9868 (Pubitemid 27408156)
41. H. Braak, and E. Braak Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 1991 239 259
42. S.E. Arnold, B.T. Hyman, J. Flory, A.R. Damasio, and G.W. Van Hoesen The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease Cereb Cortex 1 1991 103 116
43. D.R. Thal, U. Rub, M. Orantes, and H. Braak Phases of A beta-deposition in the human brain and its relevance for the development of AD Neurology 58 2002 1791 1800 (Pubitemid 34663580)
44. S.Y. Ng, V.L. Villemagne, C.L. Masters, and C.C. Rowe Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh compound B Arch Neurol 64 2007 1140 1144 (Pubitemid 47258073)
45. M.A. Mintun, G.N. Larossa, Y.I. Sheline, C.S. Dence, S.Y. Lee, and R.H. Mach et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease Neurology 67 2006 446 452 (Pubitemid 44214969)
46. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, and R.C. Petersen et al. Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects Ann Neurol 65 2009 403 413
47. H. Quigley, S.J. Colloby, and J.T. O'Brien PET imaging of brain amyloid in dementia: a review Int J Geriatr Psychiatry 26 2011 991 999
48. E.C. Mormino, J.T. Kluth, C.M. Madison, G.D. Rabinovici, S.L. Baker, and B.L. Miller et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects Brain 132 2009 1310 1323
49. C.C. Rowe, K.A. Ellis, M. Rimajova, P. Bourgeat, K.E. Pike, and G. Jones et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging Neurobiol Aging 31 2010 1275 1283
50. V.L. Villemagne, K.E. Pike, G. Chetelat, K.A. Ellis, R.S. Mulligan, and P. Bourgeat et al. Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease Ann Neurol 69 2011 181 192